References

References

1. Teno JM, Weitzen S, Fennell ML, Mor V. Dying trajectory in the last year of life: does cancer trajectory fit other diseases? J Palliat Med. 2001;4:457-464.

2. Christakis NA. Death Foretold: Prophecy and Prognosis in Medical Care. Chicago: University of Chicago Press; 1999.

3. Baile WF, Lenzi R, Parker PA, Buckman R, Cohen L. Oncologists’ attitudes toward and practices in giving bad news: an exploratory study. J Clin Oncol. 2002;20:2189-2196.

4. VandeKieft GK. Breaking bad news. Am Fam Physician. 2001;64:1975-1978.

5. Morita T, Akechi T, Ikenaga M, et al. Communication about the ending of anticancer treatment and transition to palliative care. Ann Oncol. 2004;15:1551-1557.

6. Hallenbeck J. Palliative Care Perspectives. New York: Oxford University Press; 2003.

7. Morita T, Ichiki T, Tsunoda J, Inoue S, Chihara S. A prospective study on the dying process in terminally ill cancer patients. Am J Hosp Palliat Care. 1998;15:217-222.

8. Steinhauser KE, Christakis NA, Clipp EC, McNeilly M, McIntyre L, Tulsky JA. Factors considered important at the end of life by patients, family, physicians, and other care providers. JAMA. 2000;284:2476-2482.

9. SUPPORT. A controlled trial to improve care for seriously ill hospitalized patients. The study to understand prognoses and preferences for outcomes and risks of treatments (SUPPORT). JAMA. 1995;274:1591-1598.

10. Lichter I, Hunt E. The last 48 hours of life. J Palliat Care. 1990;:7-15.

11. Ellershaw J, Smith C, Overill S, Walker SE, Aldridge J. Care of the dying: setting standards for symptom control in the last 48 hours of life. J Pain Symptom Manage. 2001;21:12-17.

12. Hall P, Schroder C, Weaver L. The last 48 hours of life in long-term care: a focused chart audit. J Am Geriatr Soc. 2002;50:501-506.

13. Teno JM, Clarridge BR, Casey V, et al Family perspectives on end-of-life care at the last place of care. JAMA. 2004;291:88-93.

14. Ventafridda V, Ripamonti C, De Conno F, Tamburini M, Cassileth BR. Symptom prevalence and control during cancer patients’ last days of life. J Palliat Care. 1990;6:7-11.

15. Coyle N, Adelhardt J, Foley KM, Portenoy RK. Character of terminal illness in the advanced cancer patient: pain and other symptoms during the last four weeks of life. J Pain Symptom Manage. 1990;5:83-93.

16. Fainsinger R, Miller MJ, Bruera E, Hanson J, Maceachern T. Symptom control during the last week of life on a palliative care unit. J Palliat Care. 1991;7:5-11.

17. Conill C, Verger E, Henriquez I, et al. Symptom prevalence in the last week of life. J Pain Symptom Manage. 1997;14:328-331.

18. Fainsinger RL. Treatment of Delirium at the End of Life: Medical and Ethical Issues. In: Portenoy RK, Bruera E, eds. Topics in Palliative Care. Vol 4. New York: Oxford University Press; 1998:261-277.

19. Breitbart W, Strout D. Delirium in the terminally ill. Clin Geriatr Med. 2000;16:357-372.

20. Lawlor P, Gagnon B. Occurrence, causes, and outcomes of delirium in patients with advanced cancer: a prospective study. Archives of Internal Medicine. 2000;160:786-794.

21. Storey P. Symptom control in dying. In: Berger Aea, ed. Principles and Practice of Supportive Oncology. Philadelphia, PA: Lippincott-Raven; 1998:741-748.

22. O’Neill B, Fallon M. ABC of palliative care. Principles of palliative care and pain control. BMJ. 1997;315:801-804.

23. Ellershaw J, Ward C. Care of the dying patient: the last hours or days of life. BMJ. 2003;326:30-34.

24. Cherny NJ, Chang V, Frager G, et al. Opioid pharmacotherapy in the management of cancer pain: a survey of strategies used by pain physicians for the selection of analgesic drugs and routes of administration. Cancer. 1995;76:1283-1293.

25. Herndon CM, Fike DS. Continuous subcutaneous infusion practices of United States hospices. J Pain Symptom Manage. 2001;22:1027-1034.

26. Chandler S. Nebulized opioids to treat dyspnea. Am J Hosp Palliat Care. 1999;16:418-422.

27. Bruera E, Macmillan K, Pither J, MacDonald RN. Effects of morphine on the dyspnea of terminal cancer patients. J Pain Symptom Manage. 1990;5:341-344.

28. Mazzocato C, Buclin T, Rapin CH. The effects of morphine on dyspnea and ventilatory function in elderly patients with advanced cancer: a randomized double-blind controlled trial. Ann Oncol. 1999;10:1511-1514.

29. Dyspnea. Mechanisms, assessment, and management: a consensus statement. Am J Respir Crit Care Med. 1999;159:321-340.

30. Jennings AL, Davies AN, Higgins JP, Gibbs JS, Broadley KE. A systematic review of the use of opioids in the management of dyspnoea. Thorax. 2002;57:939-944.

31. Campbell ML. Terminal dyspnea and respiratory distress. Crit Care Clin. 2004;20:403-417.

32. Watanabe S. The role of oxygen in cancer-related dyspnea. In: Portenoy R, Bruera E, eds. Topics in Palliative Care. Vol 4. NY: Oxford University Press; 2000:255-260.

33. Morita T, Tsuneto S, Shima Y. Definition of sedation for symptom relief: a systematic literature review and a proposal of operational criteria. J Pain Symptom Manage. 2002;24:447-453.

34. Rousseau P. Palliative sedation and sleeping before death: a need for clinical guidelines? J Palliat Med. 2003;:425-427.

35. Morita T, Tsunoda J, Inoue S, Chihara S. Effects of high dose opioids and sedatives on survival in terminally ill cancer patients. J Pain Symptom Manage. 2001;21:282-289.

36. Morita T, Hirai K, Sakaguchi Y, Tsuneto S, Shima Y. Family-perceived distress from delirium-related symptoms of terminally ill cancer patients. Psychosomatics. 2004;45:107-113.

37. Breitbart W, Gibson C, Tremblay A. The delirium experience: delirium recall and delirium-related distress in hospitalized patients with cancer, their spouses/caregivers, and their nurses. Psychosomatics. 2002;43:183-194.

38. Back IN, Jenkins K, Blower A, Beckhelling J. A study comparing hyoscine hydrobromide and glycopyrrolate in the treatment of death rattle. Palliat Med. 2001;15(4):329-336.

39. Wildiers H, Menten J. Death rattle: prevalence, prevention and treatment. J Pain Symptom Manage. 2002;23:310-317.

40. Dalal S, Bruera E. Dehydration in cancer patients: to treat or not to treat. J Support Oncol. 2004;2:467-479.

41. Byock IR. Dying Well. NY: Riverhead; 1997.

42. Byock IR. The Four Things that Matter Most: Free Press; 2004.

43. Hallenbeck J, Goldstein MK. Decisions at the end-of-life: cultural considerations beyond medical ethics. GENERATIONS. 1999; (Spring):24-29.

44. Marchand L, Kushner K. Death pronouncements: using the teachable moment in end-of-life care residency training. J Palliat Med. 2004;7:80-84.

45. Hallenbeck J, Katz S, Stratos G. End-of-Life Care Curriculum for Medical Teachers. Vol Module 3: Communicating with Patients and Families. http://www.growthhouse.org/stanford Stanford Faculty Development Center; 2003. Last accessed 3/14/05.

46. Koenig B. Cultural diversity in decisionmaking about care at the end of life. In: Field M, Cassel C, eds. Approaching Death: Improving Care at the End of Life (Institute of Medicine). Washington: National Academy Press; 1997.

47. Hallenbeck J, Goldstein MK, Mebane EW. Cultural considerations of death and dying in the United States. Clin Geriatr Med. 1996;12:393-406.

48. Hallenbeck J. Cross-cultural issues. In: Berger A, Portenoy RK, Weissman DE, eds. Principles and Practice of Palliative Care and Supportive Oncology. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 2002:661-672.

49. Pickett M. Cultural awareness in the context of terminal illness. Cancer Nursing. 1993;169:102-106.

50. Lo RS, Woo J, Zhoc KC, et al. Quality of life of palliative care patients in the last two weeks of life. J Pain Symptom Manage. 2002;24:388-397.

51. Puchalski CM. Spirituality and end-of-life care: a time for listening and caring. J Palliat Med. 2002;5:289-294.

52. Lynn J, Harrold J. Handbook for Mortals – Guidance for People Facing Serious Illness. New York: Oxford University Press; 1999.

53. Schneiderman H, Gruhn J. How–and why–to request an autopsy. Postgrad Med. Mar 1985;77:153-156.

54. McPhee SJ. Maximizing the benefits of autopsy for clinicians and families. What needs to be done. Arch Pathol Lab Med. Aug 1996;120:743-748.

55. Sinard JH. Factors affecting autopsy rates, autopsy request rates, and autopsy findings at a large academic medical center. Exp Mol Pathol. 2001;70:333-343.

56. Menkin E, Wolfson R, Weissman DE. Fast Fact and Concept #22; Writing a condolence letter. http://www.eperc.mcw.edu/ End of Life Education Project; 2000. Last accessed 3/14/05.

57. Rando T, ed. Treatment of Complicated Mourning. Champaign: Research Press; 1993.

58. Zeitlin SV. Grief and bereavement. Prim Care. 2001;28:415-425.

59. Prigerson HG, Jacobs SC. Caring for bereaved patients: “all the doctors just suddenly go”. JAMA. 2001;286:1369-76.

60. Penson RT, Dignan FL, Canellos GP, Picard CL, Lynch TJ, Jr. Burnout: caring for the caregivers. Oncologist. 2000;5:425-434.

61. Quill TE, Williamson PR. Healthy approaches to physician stress. Arch Intern Med. 1990;150:1857-1861.

62. Hallenbeck, James. Palliative care perspectives. Oxford ; New York : Oxford University Press, c2003.

Translate »